title: The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience.
authors.affiliation: State University of New York at Buffalo, School of Medicine and Biomedical Sciences, Roswell Park Center Institute, Buffalo, NY, USA.
authors.forename: P K
authors.initials: PK
authors.lastname: Duffner
authors.forename: M E
authors.initials: ME
authors.lastname: Horowitz
authors.forename: J P
authors.initials: JP
authors.lastname: Krischer
authors.forename: P C
authors.initials: PC
authors.lastname: Burger
authors.forename: M E
authors.initials: ME
authors.lastname: Cohen
authors.forename: R A
authors.initials: RA
authors.lastname: Sanford
authors.forename: H S
authors.initials: HS
authors.lastname: Friedman
authors.forename: L E
authors.initials: LE
authors.lastname: Kun
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D001932:Brain Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects; D002675:Child, Preschool; D003131:Combined Modality Therapy; D016371:Cranial Irradiation / Q000009:adverse effects; D004806:Ependymoma / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy; D005910:Glioma / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy; D006130:Growth Disorders / Q000209:etiology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008527:Medulloblastoma / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy; D015337:Multicenter Studies as Topic; D018242:Neuroectodermal Tumors, Primitive / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy; D010865:Pilot Projects; D010871:Pinealoma / Q000628:therapy; D018714:Radiotherapy, Adjuvant / Q000009:adverse effects; D016879:Salvage Therapy; D015996:Survival Rate; D016896:Treatment Outcome